...
首页> 外文期刊>Die Pharmazie >Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
【24h】

Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.

机译:酮洛芬控释基质的制定和评估以及不同辅料对释放机理的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The present work reports the study of different controlled release formulations of ketoprofen, which is a non-steroidal anti-inflammatory drug (NSAID) and like other NSAIDs requires large and frequent daily doses, resulting in severe side effects and non-compliance. To avoid these problems, controlled release matrices were developed using different grades of ethylcellulose polymer with a drug-polymer ratio of 10:3 by the direct compression method. The effect on drug release of partial replacement of lactose by different co-excipients, HPMC K100 M, starch and CMC, was also studied. The tablets were tested for their drug content, weight variation, friability, hardness, thickness and diameter, all these physical properties being within the USP range. The release profile of all formulations containing polymer and co-excipients was compared with a formulation developed without polymer and co-excipients. After a 24-hour release study, it was concluded that formulations containing different grades of ethylcellulose polymer showed prolonged release for 6-18 hours, but the formulation containing the polymer Ethocel standard FP 7 Premium without co-excipient showed controlled release for 24 hours. DSC and FT-IR studies were performed to investigate any incompatibility between drug, polymer and co-excipient but no interaction was found. Different kinetic models were used, such as first order equation, zero order equation, Higuachi equation, Hixon Crowel's equation and Korsmeyer-Peppas to study the release mechanism. The formulations containing co-excipients showed an enhanced release rate.
机译:本工作报告了对酮洛芬的不同控释制剂的研究,酮洛芬是一种非甾体类抗炎药(NSAID),与其他NSAID一样,它需要大剂量和频繁的日剂量,导致严重的副作用和违规行为。为了避免这些问题,通过直接压缩方法使用药物-聚合物比率为10:3的不同等级的乙基纤维素聚合物开发了控释基质。还研究了不同的共赋形剂HPMC K100 M,淀粉和CMC对乳糖部分替代的药物释放的影响。测试片剂的药物含量,重量变化,易碎性,硬度,厚度和直径,所有这些物理特性均在USP范围内。将所有含有聚合物和共赋形剂的制剂的释放曲线与不含聚合物和共赋形剂的制剂进行比较。经过24小时的释放研究后,得出的结论是,含有不同等级的乙基纤维素聚合物的制剂显示了6-18小时的长时间释放,但是含有聚合物Ethocel标准FP 7 Premium而没有共赋形剂的制剂显示了24小时的控制释放。进行了DSC和FT-IR研究,以研究药物,聚合物和共赋形剂之间的任何不相容性,但未发现相互作用。使用不同的动力学模型,例如一阶方程,零阶方程,Higuachi方程,Hixon Crowel方程和Korsmeyer-Peppas,研究释放机理。含有辅赋形剂的制剂显示出提高的释放速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号